Literature DB >> 19581584

Loss of phosphatidylinositol 4-kinase 2alpha activity causes late onset degeneration of spinal cord axons.

J Paul Simons1, Raya Al-Shawi, Shane Minogue, Mark G Waugh, Claudia Wiedemann, Stylianos Evangelou, Andrzej Loesch, Talvinder S Sihra, Rosalind King, Thomas T Warner, J Justin Hsuan.   

Abstract

Phosphoinositide (PI) lipids are intracellular membrane signaling intermediates and effectors produced by localized PI kinase and phosphatase activities. Although many signaling roles of PI kinases have been identified in cultured cell lines, transgenic animal studies have produced unexpected insight into the in vivo functions of specific PI 3- and 5-kinases, but no mammalian PI 4-kinase (PI4K) knockout has previously been reported. Prior studies using cultured cells implicated the PI4K2alpha isozyme in diverse functions, including receptor signaling, ion channel regulation, endosomal trafficking, and regulated secretion. We now show that despite these important functions, mice lacking PI4K2alpha kinase activity initially appear normal. However, adult Pi4k2a(GT/GT) animals develop a progressive neurological disease characterized by tremor, limb weakness, urinary incontinence, and premature mortality. Histological analysis of aged Pi4k2a(GT/GT) animals revealed lipofuscin-like deposition and gliosis in the cerebellum, and loss of Purkinje cells. Peripheral nerves are essentially normal, but massive axonal degeneration was found in the spinal cord in both ascending and descending tracts. These results reveal a previously undescribed role for aberrant PI signaling in neurological disease that resembles autosomal recessive hereditary spastic paraplegia.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19581584      PMCID: PMC2710652          DOI: 10.1073/pnas.0903011106

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Estrogen increases retrograde labeling of motoneurons: evidence of a nongenomic mechanism.

Authors:  Alexander K Murashov; Rustem R Islamov; Roger J McMurray; Elena S Pak; Douglas A Weidner
Journal:  Am J Physiol Cell Physiol       Date:  2004-03-24       Impact factor: 4.249

2.  Phosphatidylinositol kinase enzymes regulate the retrograde axonal transport of NT-3 and NT-4 in sympathetic and sensory neurons.

Authors:  Selena E Bartlett; Anna J Reynolds; Michael Weible; Ian A Hendry
Journal:  J Neurosci Res       Date:  2002-04-15       Impact factor: 4.164

3.  Impaired PtdIns(4,5)P2 synthesis in nerve terminals produces defects in synaptic vesicle trafficking.

Authors:  Gilbert Di Paolo; Howard S Moskowitz; Keith Gipson; Markus R Wenk; Sergey Voronov; Masanori Obayashi; Richard Flavell; Reiko M Fitzsimonds; Timothy A Ryan; Pietro De Camilli
Journal:  Nature       Date:  2004-09-23       Impact factor: 49.962

4.  Phosphatidylinositol 4 phosphate regulates targeting of clathrin adaptor AP-1 complexes to the Golgi.

Authors:  Ying Jie Wang; Jing Wang; Hui Qiao Sun; Manuel Martinez; Yu Xiao Sun; Eric Macia; Tomas Kirchhausen; Joseph P Albanesi; Michael G Roth; Helen L Yin
Journal:  Cell       Date:  2003-08-08       Impact factor: 41.582

5.  Milk composition and lactation of beta-casein-deficient mice.

Authors:  S Kumar; A R Clarke; M L Hooper; D S Horne; A J Law; J Leaver; A Springbett; E Stevenson; J P Simons
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

6.  The Saccharomyces cerevisiae LSB6 gene encodes phosphatidylinositol 4-kinase activity.

Authors:  Gil-Soo Han; Anjon Audhya; Daniel J Markley; Scott D Emr; George M Carman
Journal:  J Biol Chem       Date:  2002-10-01       Impact factor: 5.157

7.  Hermansky-Pudlak syndrome protein complexes associate with phosphatidylinositol 4-kinase type II alpha in neuronal and non-neuronal cells.

Authors:  Gloria Salazar; Stephanie Zlatic; Branch Craige; Andrew A Peden; Jan Pohl; Victor Faundez
Journal:  J Biol Chem       Date:  2008-11-14       Impact factor: 5.157

8.  A public gene trap resource for mouse functional genomics.

Authors:  William C Skarnes; Harald von Melchner; Wolfgang Wurst; Geoff Hicks; Alex S Nord; Tony Cox; Stephen G Young; Patricia Ruiz; Phil Soriano; Marc Tessier-Lavigne; Bruce R Conklin; William L Stanford; Janet Rossant
Journal:  Nat Genet       Date:  2004-06       Impact factor: 38.330

9.  Axonal degeneration in paraplegin-deficient mice is associated with abnormal mitochondria and impairment of axonal transport.

Authors:  Fatima Ferreirinha; Angelo Quattrini; Marinella Pirozzi; Valentina Valsecchi; Giorgia Dina; Vania Broccoli; Alberto Auricchio; Fiorella Piemonte; Giulia Tozzi; Laura Gaeta; Giorgio Casari; Andrea Ballabio; Elena I Rugarli
Journal:  J Clin Invest       Date:  2004-01       Impact factor: 14.808

10.  Phosphatidylinositol 4-kinase type IIalpha is responsible for the phosphatidylinositol 4-kinase activity associated with synaptic vesicles.

Authors:  Jun Guo; Markus R Wenk; Lorenzo Pellegrini; Franco Onofri; Fabio Benfenati; Pietro De Camilli
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-19       Impact factor: 11.205

View more
  35 in total

1.  Crucial role of phosphatidylinositol 4-kinase IIIalpha in development of zebrafish pectoral fin is linked to phosphoinositide 3-kinase and FGF signaling.

Authors:  Hui Ma; Trevor Blake; Ajay Chitnis; Paul Liu; Tamas Balla
Journal:  J Cell Sci       Date:  2009-11-03       Impact factor: 5.285

2.  Phosphatidylinositol 4,5-bisphosphate controls Rab7 and PLEKHM1 membrane cycling during autophagosome-lysosome fusion.

Authors:  Takashi Baba; Daniel J Toth; Nivedita Sengupta; Yeun Ju Kim; Tamas Balla
Journal:  EMBO J       Date:  2019-03-13       Impact factor: 11.598

Review 3.  Tied up: Does altering phosphoinositide-mediated membrane trafficking influence neurodegenerative disease phenotypes?

Authors:  Sravanthi S P Nadiminti; Madhushree Kamak; Sandhya P Koushika
Journal:  J Genet       Date:  2018-07       Impact factor: 1.166

4.  Relationship between phosphatidylinositol 4-phosphate synthesis, membrane organization, and lateral diffusion of PI4KIIalpha at the trans-Golgi network.

Authors:  Shane Minogue; K M Emily Chu; Emily J Westover; Douglas F Covey; J Justin Hsuan; Mark G Waugh
Journal:  J Lipid Res       Date:  2010-04-13       Impact factor: 5.922

Review 5.  Phosphatidylinositol 4-kinases and PI4P metabolism in the nervous system: roles in psychiatric and neurological diseases.

Authors:  Emma L Clayton; Shane Minogue; Mark G Waugh
Journal:  Mol Neurobiol       Date:  2012-10-10       Impact factor: 5.590

6.  Detergent-free isolation and characterization of cholesterol-rich membrane domains from trans-Golgi network vesicles.

Authors:  Mark G Waugh; K M Emily Chu; Emma L Clayton; Shane Minogue; J Justin Hsuan
Journal:  J Lipid Res       Date:  2010-12-29       Impact factor: 5.922

7.  Endosomal sorting of VAMP3 is regulated by PI4K2A.

Authors:  Marko Jović; Michelle J Kean; Anna Dubankova; Evzen Boura; Anne-Claude Gingras; Julie A Brill; Tamas Balla
Journal:  J Cell Sci       Date:  2014-07-07       Impact factor: 5.285

Review 8.  Phosphoinositides: tiny lipids with giant impact on cell regulation.

Authors:  Tamas Balla
Journal:  Physiol Rev       Date:  2013-07       Impact factor: 37.312

9.  Modulation of lipid kinase PI4KIIα activity and lipid raft association of presenilin 1 underlies γ-secretase inhibition by ginsenoside (20S)-Rg3.

Authors:  Min Suk Kang; Seung-Hoon Baek; Yoon Sun Chun; A Zenobia Moore; Natalie Landman; Diego Berman; Hyun Ok Yang; Maho Morishima-Kawashima; Satoko Osawa; Satoru Funamoto; Yasuo Ihara; Gilbert Di Paolo; Jeong Hill Park; Sungkwon Chung; Tae-Wan Kim
Journal:  J Biol Chem       Date:  2013-05-30       Impact factor: 5.157

10.  Type II phosphatidylinositol 4-kinase regulates trafficking of secretory granule proteins in Drosophila.

Authors:  Jason Burgess; Lauren M Del Bel; Cheng-I J Ma; Barbara Barylko; Gordon Polevoy; Janet Rollins; Joseph P Albanesi; Helmut Krämer; Julie A Brill
Journal:  Development       Date:  2012-07-12       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.